The impact of antifungals on toll-like receptors

Mircea R. Mihu, Rodney Pattabhi, Joshua D. Nosanchuk

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Fungi are increasingly recognized as major pathogens in immunocompromised individuals. With the increase in the number of fungal infections each year and the development of resistance to current therapy, new approaches to treatment including stimulation of the immune response in addition to concurrent pharmacotherapy is ongoing. The most common invasive fungal infections are caused by Candida spp., Aspergillus spp., and Cryptococcus spp. Amphotericin B (AmB) has remained the cornerstone of therapy against many fulminant fungal infections but its use is limited by its multitude of side effects. Echinocandins are a newer class of antifungal drugs with activity against Candida spp. and Aspergillus spp. and constitutes an alternative to AmB due to superior patient tolerability and fewer side effects. Due to their oral delivery, azoles continue to be heavily used for simple and complex diseases, such as fluconazole for candidal vaginitis and voriconazole for aspergillosis. The objective of this paper is to present current knowledge regarding the multiple interactions between the broad spectrum antifungals and the innate immune response, primarily focusing on the toll-like receptors.

Original languageEnglish (US)
Article numberArticle 99
JournalFrontiers in Microbiology
Volume5
Issue numberMAR
DOIs
StatePublished - 2014

Fingerprint

Toll-Like Receptors
Mycoses
Amphotericin B
Aspergillus
Candida
Echinocandins
Vaginitis
Cryptococcus
Azoles
Aspergillosis
Fluconazole
Innate Immunity
Fungi
Therapeutics
Drug Therapy
Pharmaceutical Preparations

Keywords

  • Amphotericin B
  • Antifungals
  • Caspofungin
  • Echinocandins
  • Toll-like receptors
  • Voriconazole

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

The impact of antifungals on toll-like receptors. / Mihu, Mircea R.; Pattabhi, Rodney; Nosanchuk, Joshua D.

In: Frontiers in Microbiology, Vol. 5, No. MAR, Article 99, 2014.

Research output: Contribution to journalArticle

Mihu, Mircea R. ; Pattabhi, Rodney ; Nosanchuk, Joshua D. / The impact of antifungals on toll-like receptors. In: Frontiers in Microbiology. 2014 ; Vol. 5, No. MAR.
@article{ba748baaec324e5aab6dc36a7f9005de,
title = "The impact of antifungals on toll-like receptors",
abstract = "Fungi are increasingly recognized as major pathogens in immunocompromised individuals. With the increase in the number of fungal infections each year and the development of resistance to current therapy, new approaches to treatment including stimulation of the immune response in addition to concurrent pharmacotherapy is ongoing. The most common invasive fungal infections are caused by Candida spp., Aspergillus spp., and Cryptococcus spp. Amphotericin B (AmB) has remained the cornerstone of therapy against many fulminant fungal infections but its use is limited by its multitude of side effects. Echinocandins are a newer class of antifungal drugs with activity against Candida spp. and Aspergillus spp. and constitutes an alternative to AmB due to superior patient tolerability and fewer side effects. Due to their oral delivery, azoles continue to be heavily used for simple and complex diseases, such as fluconazole for candidal vaginitis and voriconazole for aspergillosis. The objective of this paper is to present current knowledge regarding the multiple interactions between the broad spectrum antifungals and the innate immune response, primarily focusing on the toll-like receptors.",
keywords = "Amphotericin B, Antifungals, Caspofungin, Echinocandins, Toll-like receptors, Voriconazole",
author = "Mihu, {Mircea R.} and Rodney Pattabhi and Nosanchuk, {Joshua D.}",
year = "2014",
doi = "10.3389/fmicb.2014.00099",
language = "English (US)",
volume = "5",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "MAR",

}

TY - JOUR

T1 - The impact of antifungals on toll-like receptors

AU - Mihu, Mircea R.

AU - Pattabhi, Rodney

AU - Nosanchuk, Joshua D.

PY - 2014

Y1 - 2014

N2 - Fungi are increasingly recognized as major pathogens in immunocompromised individuals. With the increase in the number of fungal infections each year and the development of resistance to current therapy, new approaches to treatment including stimulation of the immune response in addition to concurrent pharmacotherapy is ongoing. The most common invasive fungal infections are caused by Candida spp., Aspergillus spp., and Cryptococcus spp. Amphotericin B (AmB) has remained the cornerstone of therapy against many fulminant fungal infections but its use is limited by its multitude of side effects. Echinocandins are a newer class of antifungal drugs with activity against Candida spp. and Aspergillus spp. and constitutes an alternative to AmB due to superior patient tolerability and fewer side effects. Due to their oral delivery, azoles continue to be heavily used for simple and complex diseases, such as fluconazole for candidal vaginitis and voriconazole for aspergillosis. The objective of this paper is to present current knowledge regarding the multiple interactions between the broad spectrum antifungals and the innate immune response, primarily focusing on the toll-like receptors.

AB - Fungi are increasingly recognized as major pathogens in immunocompromised individuals. With the increase in the number of fungal infections each year and the development of resistance to current therapy, new approaches to treatment including stimulation of the immune response in addition to concurrent pharmacotherapy is ongoing. The most common invasive fungal infections are caused by Candida spp., Aspergillus spp., and Cryptococcus spp. Amphotericin B (AmB) has remained the cornerstone of therapy against many fulminant fungal infections but its use is limited by its multitude of side effects. Echinocandins are a newer class of antifungal drugs with activity against Candida spp. and Aspergillus spp. and constitutes an alternative to AmB due to superior patient tolerability and fewer side effects. Due to their oral delivery, azoles continue to be heavily used for simple and complex diseases, such as fluconazole for candidal vaginitis and voriconazole for aspergillosis. The objective of this paper is to present current knowledge regarding the multiple interactions between the broad spectrum antifungals and the innate immune response, primarily focusing on the toll-like receptors.

KW - Amphotericin B

KW - Antifungals

KW - Caspofungin

KW - Echinocandins

KW - Toll-like receptors

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=84897930162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897930162&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2014.00099

DO - 10.3389/fmicb.2014.00099

M3 - Article

AN - SCOPUS:84897930162

VL - 5

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - MAR

M1 - Article 99

ER -